RETRACTED: Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).

This article has been retracted at the request of author Stanley Rapoport, with approval from Biological Psychiatry Editor, John H. Krystal, MD.

The National Institutes of Health has found that Dr. Jagadeesh S. Rao engaged in research misconduct by falsifying data in Figures 1, 3, and 5 of the aforementioned manuscript. No other authors were implicated in the data falsification
Rao
Jagadeesh S
JS
Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA. jrao@mail.nih.gov
Bazinet
Richard P
RP
Rapoport
Stanley I
SI
Lee
Ho-Joo
HJ
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D018692:Antimanic Agents / Q000494:pharmacology*; D016718:Arachidonic Acid / Q000378:metabolism; D001714:Bipolar Disorder / Q000235:genetics / Q000503:physiopathology; D002220:Carbamazepine / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects; D005625:Frontal Lobe / Q000187:drug effects*; D005786:Gene Expression Regulation / Q000187:drug effects; D008297:Male; D010741:Phospholipases A / Q000235:genetics / Q000378:metabolism; D054467:Phospholipases A2; D051381:Rats; D011919:Rats, Inbred Strains; D050656:Transcription Factor AP-2 / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*
D000927:Anticonvulsants; D018692:Antimanic Agents; D050656:Transcription Factor AP-2; D014157:Transcription Factors; D016718:Arachidonic Acid; D002220:Carbamazepine; D010741:Phospholipases A; D054467:Phospholipases A2